BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 67485)

  • 1. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in Diabetes mellitus.
    Irvine WJ; Sawers JS; Feek CM; Prescott RJ; Duncan LJ
    J Clin Lab Immunol; 1979 Apr; 2(1):23-6. PubMed ID: 95802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose and insulin responses to oral glucose in overt non-insulin-dependent diabetics with and without the islet cell antibody.
    Gray RS; Irvine WJ; Cameron EH; Duncan LJ
    Diabetes; 1980 Apr; 29(4):312-6. PubMed ID: 6987121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.
    MacCuish AC; Irvine WJ; Barnes EW; Duncan LJ
    Lancet; 1974 Dec; 2(7896):1529-31. PubMed ID: 4140978
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
    Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
    J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined administration of oral agents in insulin therapy].
    Oneta A
    Nihon Rinsho; 1973 Jul; 31(7):2293-7. PubMed ID: 4795330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined administration of insulin and oral agents].
    Tasaka H
    Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.
    Irvine WJ; Gray RS; McCallum CJ
    Lancet; 1976 Nov; 2(7995):1097-102. PubMed ID: 62945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
    Peters WH; Lester FT; Kohnert KD; Hildmann W
    Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
    Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
    Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet-cell antibodies in diabetes mellitus.
    Lendrum R; Walker G; Cudworth AG; Theophanides C; Pyke DA; Bloom A; Gamble DR
    Lancet; 1976 Dec; 2(7998):1273-6. PubMed ID: 63747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Islet cell antibodies in diabetes mellitus (author's transl)].
    Pujol-Borrell R; Richart C
    Med Clin (Barc); 1980 Mar; 74(5):163-9. PubMed ID: 6991837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics.
    Sakurami T; Nagaoka K; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1980 Apr; 27(2):149-52. PubMed ID: 6997023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.